<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02752698</url>
  </required_header>
  <id_info>
    <org_study_id>XY3-DSRCS1507A01</org_study_id>
    <nct_id>NCT02752698</nct_id>
  </id_info>
  <brief_title>Domestic Surgical Robot Clinical Study</brief_title>
  <official_title>Safety and Feasible Study of Domestic Surgical Robot That Had Been Authorized to Enter the Clinical Trial Stage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Third Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Third Xiangya Hospital of Central South University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central South University in collaboration with Tianjin University developed the first
      domestically produced Chinese minimally invasive surgical (MIS) robot system which named
      &quot;Micro Hand S&quot; in 2013. Recently, as the domestic surgical robot research project's main
      section, this new MIS robot had been authorized to enter the clinical trial stage by the
      Ethics Committee of the Third Xiangya Hospital at Central South University.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One surgeon perform these surgical trials using the robot &quot;Micro Hand S&quot;. All of the patients
      were followed for 1 months, and pre- and postoperative changes in blood route test and
      hepatorenal function examination, surgery duration, hospital stay, total robotic setup time,
      total robotic operation time, intraoperative blood loss, total postoperative drainage amount,
      duration of bearing drainage tubes were recorded.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 1, 2015</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of white blood cell at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>white blood cell in10^9/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of hemoglobin test at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>hemoglobin in g/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of alanine aminotransferase examination at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>alanine aminotransferase in U/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of glutamate aminotransferase examination at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>glutamate aminotransferase in U/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of total bilirubin examination at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>total bilirubin in μmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of direct bilirubin examination at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>direct bilirubin in μmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of albumin examination at 3 months</measure>
    <time_frame>3 months after operation</time_frame>
    <description>albumin in g/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymph node retrieval number</measure>
    <time_frame>postoperation</time_frame>
    <description>lymph node retrieval number in operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood loss</measure>
    <time_frame>in operation</time_frame>
    <description>blood loss in operation(in ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operation time</measure>
    <time_frame>in operation</time_frame>
    <description>operation time (in min)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gastric Ulcer With Perforation But Without Obstruction</condition>
  <condition>Colon Cancer</condition>
  <condition>Cholecystolithiasis</condition>
  <condition>Appendicitis</condition>
  <condition>Sleeve Gastrectomy</condition>
  <condition>Gastric Bypass</condition>
  <condition>Gastric Cancer</condition>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Micro Hand S robotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Micro Hand S robotic surgery group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>laparoscopic surgery group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Micro Hand S robotic surgery</intervention_name>
    <description>30 patients undergo Micro Hand S robotic surgeries</description>
    <arm_group_label>Micro Hand S robotic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic surgery</intervention_name>
    <description>30 patients undergo laparoscopic surgeries</description>
    <arm_group_label>laparoscopic surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of gastric tumor, colorectal tumor, acute cholecystitis and ileocecal tumor
             respectively

          -  18years&lt;age&lt;65years

          -  male or female

        Exclusion Criteria:

          -  patients with a history of open abdominal surgery

          -  unstable psychiatric illness

          -  an inability or reluctance to cooperate during long-term follow-up

          -  alcohol or drug addiction

          -  or relatively high surgical risks, such as abnormal coagulation function or bad heart,
             lung, liver and kidney function, were excluded from this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>shaihong zhu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Third Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Third Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 15, 2015</study_first_submitted>
  <study_first_submitted_qc>April 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2016</study_first_posted>
  <last_update_submitted>December 25, 2019</last_update_submitted>
  <last_update_submitted_qc>December 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
    <mesh_term>Stomach Ulcer</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

